A 2023 study released within the journal Lancet Oncology identified disruptions in treatment amid the pandemic also resulted in a rise in late-phase diagnoses across almost all cancer types, which includes prostate. On the other hand, micrometastases are excluded from this threat group. This also applies to the irradiation of interior mammary lym